By Dr. Arun Chaudhary, Chairman, IDC India — Innovation Development Council
The scale of the sector
Healthcare and life sciences is now among the top sectors by number of DPIIT-recognised startups claiming Section 80-IAC tax benefits, alongside IT services, construction, agriculture and professional services — out of the 1,97,692 startups DPIIT had recognised as of October 2025, per a written reply tabled in the Lok Sabha by Commerce Minister Piyush Goyal [Lok Sabha written reply via Piyush Goyal, tabled October 2025, reported by Inc42, "India Home To Nearly 2 Lakh DPIIT-Recognised Startups"]. Independent market-intelligence data puts India's HealthTech sector specifically at roughly 14,000–15,000 companies, of which around 1,650 are funded, having collectively raised over $10 billion in venture capital, with six having reached unicorn status [Tracxn, "HealthTech in India — 2026 Market & Investments Trends", as of early 2026]. Healthtech attracted an estimated $828 million in the first half of 2025 alone, making it the second-most-funded startup vertical in the country that half-year, behind only e-commerce-adjacent sectors [Beacon Filing / Inc42-Tracxn-TechCrunch consolidated data, "India Startup Funding Report 2025"]. This is not a marginal category of India's startup economy; it is one of its largest by both company count and capital.
Where clinicians are visible — and where they aren't
Clinician-founders do exist, and are increasingly visible in press coverage. Cloudphysician, a Bengaluru remote-ICU platform, was founded in 2017 by Dr. Dhruv Joshi and Dr. Dileep Raman, both described in reporting as trained doctors who built the company around a gap they encountered directly in clinical practice [Forbes India, "Chronic problems, fresh solutions: How health tech startups are reinventing care", 2025]. Other doctor-led ventures — including transitional-care and dermatology-led startups — are cited in similar profiles as founder-operators, not advisors [Medicircle, "The rise of health-tech startups led by doctors themselves", 2025].
But a second, more common pattern also shows up in the same coverage: clinicians present as an advisory layer around a venture, rather than inside its ownership structure. Qure.ai, an AI diagnostics company, is reported as founded by a data-science and business background team, with "an advisory panel [of] radiologists, doctors, and public health experts who work with the team to define clinically relevant problems" [Global Indian, "5 Indian healthtech startups that empower doctors with their innovation", 2025]. This advisory-panel structure — clinical expertise informing the product without appearing on the cap table or in governance — recurs across multiple profiles of India's larger, better-funded health-innovation companies, though no single dataset tracks founder clinical background systematically across the sector, and this piece does not claim one does.
A structural mechanism, not just a preference
One plausible reason for this pattern is straightforwardly regulatory, not cultural. A large share of India's practising physicians are government employees — at central, state, or public-hospital level — and are therefore governed by service conduct rules that predate the startup economy entirely. Rule 15 of the Central Civil Services (Conduct) Rules, 1964 states that "no Government servant shall, except with the previous sanction of the Government — (a) engage directly or indirectly in any trade or business; or (b) negotiate for, or undertake, any other employment... or (e) take part... in the registration, promotion or management of any bank or other company registered... under the Companies Act" [Central Civil Services (Conduct) Rules, 1964, Rule 15, Department of Personnel & Training]. State medical and health service conduct rules generally mirror this structure for government doctors specifically.
This is a Tier 1, checkable regulatory fact, not speculation about anyone's individual motive: a serving government doctor cannot, without prior sanction, hold a formal role in the "registration, promotion or management" of a private company — precisely the language that would cover a founder or director role in a health-innovation startup. A government doctor can chair a governance body, sit on an advisory board, or hold an unpaid clinical-advisor role more readily than they can hold a proprietorial or director-level position in a commercial entity, without seeking explicit sanction. Where India's most clinically credentialed people are disproportionately employed by the state, this rule alone would predict exactly the advisory-layer pattern visible in press coverage — independent of how many of those clinicians might otherwise want to found companies.
Counter-evidence
The pattern is not absolute. Cloudphysician's and other doctor-founded ventures cited above indicate that private-practice physicians, or those who have exited government service, face no such constraint and do found and lead companies directly. International context, cautiously: physician entrepreneurship is reported to be rising sharply in other large healthcare markets too — one industry publication cites roughly four in ten U.S. doctors now pursuing ventures beyond clinical practice, alongside several billion-dollar physician-founded exits [Top Doctor Magazine, "Healthcare Innovation Startup Doctors: Clinic to Founder", 2026] — suggesting the pull toward founding is not uniquely weak among Indian clinicians as a class. It may instead be selectively suppressed among the subset who remain in government service, which in India is a large subset given the scale of public healthcare employment.
What this does and doesn't establish
The evidence supports a bounded claim: India's health-innovation sector is large, fast-growing, and well-capitalised; clinician-founders are present and visible in press coverage but co-exist with a distinct and more common pattern of clinicians occupying advisory rather than governance or ownership roles; and a specific, checkable conduct rule governing government employees offers a plausible structural explanation for at least part of that pattern, independent of preference or capability.
What the evidence does not establish is a quantified answer — no public dataset tracks the clinical-background composition of India's health-innovation founder pool at scale, so any claim about what share of clinicians are pushed into advisory roles by this mechanism, versus choosing it, would outrun the available data. That is the open empirical question India's startup-data infrastructure — DPIIT, ministry reporting, or a dedicated sector survey — is best placed to answer next.
As of the dates cited above. Figures drawn from Tracxn, Inc42/Beacon Filing consolidated funding data, and DPIIT/Lok Sabha disclosures will change with future reporting cycles and should be re-verified before reuse beyond this piece's publication window.
